NN

Neelam Nagendraprasad Tiwari

Active Director Director DIN 11045759
DIN 11045759 First appointment Apr 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Neelam Nagendraprasad Tiwari

Data last updated:

Neelam Nagendraprasad Tiwari is a Director at Aqutez Lifesciences Private Limited (since 2025). The company operates in Pharma.

DIN 11045759
Primary Designation Director
Industry Pharma
First Appointment 08 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aqutez Lifesciences Private Limited U21001MH2025PTC445147
Director08 Apr 20252025Active

Board colleagues of Neelam Nagendraprasad Tiwari

NameDINCompanyDesignation
Pratima Tiwari11045760Aqutez Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aqutez Lifesciences Private Limited
Premium access

Shareholding and investment profile for Neelam Nagendraprasad Tiwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neelam Nagendraprasad Tiwari

Neelam Nagendraprasad Tiwari currently holds 1 directorship: Aqutez Lifesciences Private Limited (Director, since 08 Apr 2025).

Neelam Nagendraprasad Tiwari was first appointed on 08 Apr 2025 as Director at Aqutez Lifesciences Private Limited.

The current boards of Neelam Nagendraprasad Tiwari's companies include Pratima Tiwari (Aqutez Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available